[ZOHYDRO] Maker Of Opioid Painkiller Sues Massachusetts Over Ban On Sale

        The AP (4/8) provided background information, noting that in March, Gov. Patrick “declared a public health emergency in response to the state’s growing epidemic of heroin and opioid addiction.” The AP noted that the governor “gave the state public health commissioner certain emergency powers, including banning Zohydro” until safeguards are in place to prevent … Continue reading


  H.R. 1801: Cancer Drug Coverage Parity Act of 2013 – To amend the Employee Retirement Income Security Act of 1974, the Public Health Service Act, and the Internal Revenue Code of 1986 to require group and individual health insurance coverage and group health plans to provide for coverage of oral anticancer drugs on terms … Continue reading

Breast Cancer Deadline 2020® Third Annual Progress Report Released

Today, NBCC is releasing their Breast Cancer Deadline 2020® Third Annual Progress Report to the public. Each year since the launch of Breast Cancer Deadline 2020®, NBCC has released an annual report on the progress in breast cancer and in NBCC’s work to achieve the deadline. This year’s report provides an update with the latest data … Continue reading

Impasse Implications Impact Illness: Federal Shutdown Has Real Consequences on Patients With Cancer & Nurses

Federal Shutdown Has Real Consequences on Patients With Cancer  and Their Nurses   As the U.S. Congress continues to debate the details of the federal budget, Americans with cancer are stuck in limbo. The Oncology Nursing Society (ONS) has urged elected officials to find a resolution with appropriate funding for healthcare providers and patients with … Continue reading

[LEGISLATIVE UPDATE] Compounding Pharmacy Regulation Bill Passes House

  The Wall Street Journal (9/28, Burton, Subscription Publication) reported that on Saturday, the House passed a bill to increase the Food and Drug Administration’s regulatory authority over compounding pharmacies, in response to the meningitis outbreak last year caused by tainted steroid injections from a compounding pharmacy. On Friday, a written statement issued by the … Continue reading

Perjeta Granted Accelerated Approval for Neoadjuvant Breast Cancer

Today, the FDA granted accelerated approval to Perjeta (pertuzumab; Genentech) as part of a neoadjuvant treatment regimen for patients with high-risk, HER2-positive, early-stage breast cancer.  Perjeta is the first FDA-approved drug for the neoadjuvant treatment of breast cancer, and the first to be approved based on pathologic complete response data. Read more: http://www.chemotherapyadvisor.com/perjeta-granted-accelerated-approval-for-neoadjuvant-breast-cancer/article/314031/?DCMP=EMC-CTA_Front&CPN=&spMailingID=7069369&spUserID=MjI1ODk5NzA1NTQS1&spJobID=90921269&spReportId=OTA5MjEyNjkS1  

Breaking News: Senate Releases Draft Compounding Legislation

This week Republican and Democrat staffers from the Senate Committee on Health Education, Labor, and Pensions (HELP) met to discuss the provisions included in an early version of bipartisan legislation to address regulatory gaps in oversight of compounding outsourcers The advocacy community has been actively engaged with HELP Committee staff as they have developed legislative … Continue reading

Physicians Group Blames Drug Shortages On GPOs.

See on Scoop.it – Advocacy Action & Issues in Cancer Heather Swift‘s insight:   Medscape (1/25, Nelson) reports that although “a number of reasons have been cited” for the ongoing drug shortages, the Physicians Against Drug Shortages lays the blame “firmly at the feet of group purchasing organizations (GPOs),” arguing that the “real reason for … Continue reading

ACCC Urges Faster Congressional Action to Confront Drug Shortage Crisis

ACCC Urges Faster Congressional Action to Confront Drug Shortage Crisis The Association of Community Cancer Centers (ACCC) joined 31 other medical organizations in urging House Energy and Commerce Committee Chairman Fred Upton to move forward with legislation to combat the drug shortage crisis. While acknowledging that drug shortages cannot be solved by Congressional action alone, … Continue reading